Dauch Corp

1. 1

   Election of 3 members of the Board of Directors to serve until the annual meeting of stockholders in 2029

   ManagementBoard: FOR

   Elect three Class III directors (Sandra E. Pierce, James A. McCaslin, and Terry Grayson-Caprio) to serve three-year terms ending in 2029.

2. 2

   Advisory vote on named executive officer compensation

   ManagementBoard: FOR

   Non-binding advisory (Say-on-Pay) vote to approve the compensation of the Company's named executive officers as disclosed in the Compensation Discussion and Analysis and accompanying tables.

   More detail

   This proposal asks shareholders to cast a non-binding advisory vote to approve the compensation of the named executive officers as disclosed in the CD&A and related tables. Management frames the request as a validation of a market-based, performance-driven compensation program that emphasizes substantial at‑risk pay tied to operational and cash flow metrics, a sustainability component, and long-term incentive designs linking pay to adjusted free cash flow and relative TSR. The Board emphasizes that the advisory vote does not bind the company but that compensation decisions will reflect shareholder feedback; it notes prior years’ engagement and that the 2025 say‑on‑pay passed but with reduced support, prompting expanded outreach and adjustments in disclosure and program features. Management highlights tangible program design elements—60% performance-based LTI mix, operational cash flow and adjusted EBITDA weighting in annual incentives, and forthcoming synergy‑linked LTI elements—to demonstrate alignment with shareholder value creation and post‑Combination integration objectives. The Board recommends FOR, arguing that the program supports retention and performance during a multi‑year integration following the Dowlais acquisition, while balancing cash preservation with equity‑based incentives to reduce cash outflow. Potential investor concerns include realized pay versus realized performance (TSR volatility), dilution from equity grants, and whether newly introduced Breakout Performance Awards and synergy metrics will be sufficiently rigorous and measurable. The company counters by describing specific governance safeguards (relative TSR modifiers, clawback policies, double‑trigger CIC provisions, and minimum vesting) and by committing to continued shareholder engagement and disclosure on calibration and outcomes. For an analyst evaluating governance and pay‑for‑performance, the central issues are whether the stated metrics and the rigorous calibration (including TSR modifiers and phased LTI grants tied to integration synergies) will produce measurable alignment over a multi‑year window and whether disclosure and engagement will remain responsive should shareholder support remain muted.

3. 3

   Approval of Amended and Restated 2018 Omnibus Incentive Plan

   ManagementBoard: FOR

   Seek shareholder approval to increase the share pool under the 2018 Omnibus Incentive Plan by 9,000,000 shares and to adopt the Amended and Restated 2018 Omnibus Incentive Plan with updated terms.

   More detail

   This management proposal requests shareholder approval to amend and restate the 2018 Omnibus Incentive Plan to add 9,000,000 additional shares for equity awards, increasing total plan capacity to support post‑Combination operations. Management argues the increase is necessary after the Dowlais acquisition, which materially expanded the company’s scale and headcount while nearly doubling outstanding shares, leaving the existing plan insufficient for anticipated LTI and retention grants. The Board frames the request as enabling continued use of equity‑based incentives—key to aligning executive and employee interests with long‑term shareholder value—while targeting a multi‑year runway (approximately three years) and limiting potential dilution to roughly 9.3% of outstanding shares on a fully diluted basis. The proposal highlights governance protections in plan design—minimum 12‑month vesting, double‑trigger CIC acceleration, no evergreen increase, clawbacks, TSR/performance modifiers, and Compensation Committee administration—to mitigate shareholder concerns about dilution and poor pay‑for‑performance alignment. Management further notes the company’s historical burn rate (~2.1% average) and that failure to approve would force heavier cash‑based compensation, increasing cash outlays and potentially weakening capital allocation flexibility. Key investor considerations include the sufficiency of the proposed share amount given integration plans and potential dilution, the expected pace and recipients of future grants (executive vs. broad employee grants), and whether robust performance conditions and disclosure will accompany future grants to ensure clear pay‑for‑performance alignment. The Board recommends FOR, arguing the plan balance and stated safeguards justify approval to maintain competitiveness and support the multi‑year integration and growth objectives.

4. 4

   Ratification of the appointment of Deloitte & Touche LLP as independent public accounting firm for 2026

   ManagementBoard: FOR

   Ratify Deloitte & Touche LLP as Dauch’s independent registered public accounting firm for the year ending December 31, 2026.

Upcoming shareholder meetings at Dauch Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.

When is the Dauch Corp 2026 annual meeting?

Dauch Corp (DCH) holds its 2026 annual shareholder meeting on Thursday, April 30, 2026.

What is the record date for the Dauch Corp 2026 meeting?

The record date for the Dauch Corp 2026 meeting is Thursday, March 5, 2026. Shareholders of record on or before that date are eligible to vote.

Who are the director nominees for Dauch Corp's 2026 meeting?

The board is presenting 3 director nominees at the Dauch Corp 2026 meeting, listed with their independence status and background.

What proposals will shareholders vote on at the Dauch Corp 2026 meeting?

Shareholders will vote on 4 proposals at the Dauch Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.